Cassidy Bernard J
Insider CIK 1398322 · TSRA EVP & General Counsel · JUNO General Counsel and Secretary · SANA EVP & General Counsel
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| SANA Sana Biotechnology, Inc. | F Tax w/h | 2025-03-10 | 2025-03-10 | 2,833 | $2.56 | $7.3K | 112,990 | SEC↗ |
| SANA Sana Biotechnology, Inc. | M Exercise deriv | 2025-03-07 | 2025-03-10 | 11,041 | — | $0 | 33,126 | SEC↗ |
| SANA Sana Biotechnology, Inc. | M Exercise | 2025-03-07 | 2025-03-10 | 11,041 | — | $0 | 115,823 | SEC↗ |
| SANA Sana Biotechnology, Inc. | A Award deriv | 2025-03-06 | 2025-03-10 | 53,333 | — | $0 | 53,333 | SEC↗ |
| SANA Sana Biotechnology, Inc. | A Award deriv | 2025-03-06 | 2025-03-10 | 240,000 | — | $0 | 240,000 | SEC↗ |
| SANA Sana Biotechnology, Inc. | A Award deriv | 2024-03-07 | 2024-03-08 | 198,750 | — | $0 | 198,750 | SEC↗ |
| SANA Sana Biotechnology, Inc. | A Award deriv | 2024-03-07 | 2024-03-08 | 44,167 | — | $0 | 44,167 | SEC↗ |
| SANA Sana Biotechnology, Inc. | A Award deriv | 2023-03-02 | 2023-03-03 | 140,000 | — | $0 | 140,000 | SEC↗ |
| SANA Sana Biotechnology, Inc. | A Award deriv | 2022-09-15 | 2022-09-16 | 800,000 | — | $0 | 800,000 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | D To issuer deriv | 2018-03-05 | 2018-03-07 | 125,000 | — | $0 | 0 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | D To issuer deriv | 2018-03-05 | 2018-03-07 | 37,500 | — | $0 | 0 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | D To issuer deriv | 2018-03-05 | 2018-03-07 | 75,000 | — | $0 | 0 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | D To issuer deriv | 2018-03-05 | 2018-03-07 | 113,636 | — | $0 | 0 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | D To issuer deriv | 2018-03-05 | 2018-03-07 | 50,500 | — | $0 | 0 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | U Tender | 2018-03-05 | 2018-03-07 | 26,869 | $87.00 | $2.34M | 0 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | D To issuer | 2018-03-05 | 2018-03-07 | 35,893 | — | $0 | 0 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | D To issuer | 2018-03-05 | 2018-03-07 | 25,639 | — | $0 | 35,893 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | D To issuer | 2018-03-05 | 2018-03-07 | 18,293 | — | $0 | 61,532 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | U Tender | 2018-03-05 | 2018-03-07 | 5,558 | $87.00 | $483.5K | 79,825 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | G Gift | 2018-02-07 | 2018-02-09 | 26,634 | — | $0 | 85,262 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | F Tax w/h | 2018-02-07 | 2018-02-09 | 1,528 | $85.49 | $130.6K | 111,896 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | A Award | 2018-01-31 | 2018-02-02 | 25,639 | — | $0 | 113,424 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | A Award | 2017-10-20 | 2017-10-20 | 35,893 | — | $0 | 86,917 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | S Sale | 2017-09-14 | 2017-09-14 | 3,441 | $45.90 | $157.9K | 52,529 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | S Sale | 2017-09-14 | 2017-09-14 | 1,505 | $46.58 | $70.1K | 51,024 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | S Sale | 2017-09-14 | 2017-09-14 | 23,054 | $44.67 | $1.03M | 55,970 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | A Award deriv | 2017-02-07 | 2017-02-09 | 113,636 | — | $0 | 113,636 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | A Award | 2017-02-07 | 2017-02-09 | 24,390 | — | $0 | 79,024 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | S Sale | 2016-05-19 | 2016-05-20 | 877 | $39.69 | $34.8K | 54,634 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | S Sale | 2016-05-19 | 2016-05-20 | 2,239 | $38.77 | $86.8K | 55,511 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | S Sale | 2016-04-19 | 2016-04-19 | 650 | $43.60 | $28.3K | 57,283 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | S Sale | 2016-04-19 | 2016-04-19 | 2,550 | $43.00 | $109.7K | 57,933 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | S Sale | 2016-03-18 | 2016-03-18 | 1,818 | $37.96 | $69.0K | 61,865 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | S Sale | 2016-03-18 | 2016-03-18 | 1,382 | $38.47 | $53.2K | 60,483 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | S Sale | 2016-02-19 | 2016-02-19 | 200 | $35.21 | $7.0K | 63,683 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | S Sale | 2016-02-19 | 2016-02-19 | 3,000 | $34.45 | $103.4K | 63,883 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | A Award deriv | 2016-02-02 | 2016-02-04 | 75,000 | — | $0 | 75,000 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | S Sale | 2016-01-19 | 2016-01-20 | 800 | $34.12 | $27.3K | 66,883 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | S Sale | 2016-01-19 | 2016-01-20 | 2,400 | $33.37 | $80.1K | 67,683 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | S Sale | 2015-12-18 | 2015-12-21 | 1,890 | $45.02 | $85.1K | 71,393 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | S Sale | 2015-12-18 | 2015-12-21 | 1,310 | $45.92 | $60.2K | 70,083 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | S Sale | 2015-11-19 | 2015-11-20 | 2,895 | $52.91 | $153.2K | 71,505 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | S Sale | 2015-11-19 | 2015-11-20 | 305 | $53.56 | $16.3K | 71,200 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | S Sale | 2015-10-19 | 2015-10-19 | 1,836 | $50.17 | $92.1K | 74,400 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | S Sale | 2015-10-19 | 2015-10-19 | 1,364 | $49.42 | $67.4K | 76,236 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | S Sale | 2015-09-18 | 2015-09-18 | 3,020 | $43.08 | $130.1K | 77,600 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | S Sale | 2015-09-18 | 2015-09-18 | 8,830 | $42.30 | $373.5K | 80,620 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | S Sale | 2015-08-19 | 2015-08-20 | 10,450 | $40.06 | $418.6K | 90,850 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | S Sale | 2015-08-19 | 2015-08-20 | 1,400 | $40.76 | $57.1K | 89,450 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | S Sale | 2015-07-17 | 2015-07-17 | 10,200 | $50.45 | $514.6K | 102,950 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | S Sale | 2015-07-17 | 2015-07-17 | 1,650 | $51.12 | $84.3K | 101,300 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | S Sale | 2015-06-24 | 2015-06-25 | 2,295 | $51.83 | $118.9K | 113,150 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | S Sale | 2015-06-24 | 2015-06-25 | 9,555 | $51.22 | $489.4K | 115,445 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | A Award deriv | 2015-03-03 | 2015-03-05 | 50,500 | — | $0 | 50,500 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | C Conversion deriv | 2014-12-23 | 2015-01-15 | 1,869 | — | $0 | 0 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | C Conversion deriv | 2014-12-23 | 2015-01-15 | 25,000 | — | $0 | 0 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | C Conversion | 2014-12-23 | 2015-01-15 | 25,000 | — | $0 | 25,000 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | C Conversion | 2014-12-23 | 2015-01-15 | 1,869 | — | $0 | 26,869 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | C Conversion deriv | 2014-12-23 | 2014-12-23 | 1,689 | — | $0 | 0 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | C Conversion deriv | 2014-12-23 | 2014-12-23 | 25,000 | — | $0 | 0 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | C Conversion | 2014-12-23 | 2014-12-23 | 25,000 | — | $0 | 25,000 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | C Conversion | 2014-12-23 | 2014-12-23 | 1,689 | — | $0 | 26,689 | SEC↗ |
| TSRA TESSERA TECHNOLOGIES INC | D To issuer | 2013-03-06 | 2013-03-07 | 4,486 | — | $0 | 41,250 | SEC↗ |
| TSRA TESSERA TECHNOLOGIES INC | S Sale | 2013-03-06 | 2013-03-07 | 3,014 | $17.75 | $53.5K | 45,736 | SEC↗ |
| TSRA TESSERA TECHNOLOGIES INC | S Sale | 2013-02-01 | 2013-02-04 | 1,782 | $17.49 | $31.2K | 48,750 | SEC↗ |
| TSRA TESSERA TECHNOLOGIES INC | A Award deriv | 2013-01-14 | 2013-01-16 | 86,000 | — | $0 | 86,000 | SEC↗ |
| TSRA TESSERA TECHNOLOGIES INC | A Award | 2013-01-14 | 2013-01-16 | 10,000 | — | $0 | 48,750 | SEC↗ |
| TSRA TESSERA TECHNOLOGIES INC | S Sale | 2012-12-24 | 2012-12-27 | 5,094 | $16.29 | $83.0K | 38,750 | SEC↗ |
| TSRA TESSERA TECHNOLOGIES INC | F Tax w/h | 2012-11-19 | 2012-11-20 | 1,833 | $14.53 | $26.6K | 43,844 | SEC↗ |
| TSRA TESSERA TECHNOLOGIES INC | A Award deriv | 2012-09-12 | 2012-09-14 | 45,000 | — | $0 | 45,000 | SEC↗ |
| TSRA TESSERA TECHNOLOGIES INC | A Award | 2012-09-12 | 2012-09-14 | 20,000 | — | $0 | 45,677 | SEC↗ |
| TSRA TESSERA TECHNOLOGIES INC | D To issuer | 2012-02-15 | 2012-02-17 | 3,646 | — | $0 | 25,677 | SEC↗ |
| TSRA TESSERA TECHNOLOGIES INC | S Sale | 2012-02-15 | 2012-02-17 | 1,927 | $19.24 | $37.1K | 27,604 | SEC↗ |
| TSRA TESSERA TECHNOLOGIES INC | S Sale | 2012-02-01 | 2012-02-02 | 1,606 | $19.63 | $31.5K | 31,250 | SEC↗ |